SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-329908
Filing Date
2020-12-30
Accepted
2020-12-30 17:00:30
Documents
12
Period of Report
2020-12-28
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d101879d8k.htm   iXBRL 8-K 25491
  Complete submission text file 0001193125-20-329908.txt   151662

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ziop-20201228.xsd EX-101.SCH 3092
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20201228_lab.xml EX-101.LAB 18909
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20201228_pre.xml EX-101.PRE 11878
5 EXTRACTED XBRL INSTANCE DOCUMENT d101879d8k_htm.xml XML 3539
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 201426492
SIC: 2834 Pharmaceutical Preparations